Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Testing and health monitoring news

Show

From To
Darunavir/ritonavir most durable boosted protease inhibitor in European patients, especially those switching treatment for any reason

Darunavir/ritonavir is the most durable boosted protease inhibitor for antiretroviral (ART)-experienced patients, investigators from the EuroSIDA cohort report in HIV Medicine. Patients switching treatment to

Published
13 February 2018
By
Michael Carter
Multi-disease testing offers new ways to streamline disease management, Unitaid report says

Innovators are responding to the world’s growing co-infection crisis by developing devices that can quickly, accurately diagnose multiple diseases at a time. Unitaid’s new landscape report, launched today, profiles more than 95 such devices, already on the market or in development, all of which address at least one of Unitaid’s key disease areas—HIV, hepatitis C (HCV), tuberculosis (TB) and malaria.

Published
02 February 2018
From
Unitaid
Study finds more than half of patients worldwide don’t access HIV treatment until immune systems are severely compromised

Data from nearly a million patients starting treatment for HIV across the world over the last decade shows 55 percent of them accessed antiretroviral treatment only after their immune cell — or CD4 — counts had dropped below 200, leaving them extremely vulnerable to illnesses and infections.

Published
02 February 2018
From
Science Speaks
A More Sensitive Saliva-Based HIV Test Is in the Works

Preliminary experiments suggest that the investigatory saliva test can identify HIV earlier in the course of infection compared with currently available spit-based assays. However, this experimental test will not likely identify new HIV infections as early as a blood test can.

Published
25 January 2018
From
Poz
Using social and risk networks helps identify people undiagnosed with HIV

Conducting HIV testing among the social and risk networks of those recently diagnosed with HIV helps identify undiagnosed cases of HIV at significantly higher rates and at a lower cost than other testing approaches, finds a new study conducted in Ukraine by an international research team.

Published
22 January 2018
From
Eurekalert Inf Dis
Faster action on adherence is needed after viral load becomes detectable, researchers warn global treatment programmes

Low-level HIV viral load, above the limit of detection, is an important warning signal for future treatment failure and World Health Organization guidelines on spotting treatment failure

Published
12 January 2018
By
Keith Alcorn
High cholesterol and diabetes common among people on HIV treatment in Malawi

High LDL cholesterol levels and diabetes are much more common in people living with HIV on long-term antiretroviral treatment in Malawi compared to people of

Published
04 January 2018
By
Keith Alcorn
Internet-based STI testing nearly doubles uptake vs. clinic visits

Introducing patients to internet-based STI testing services could increase testing uptake compared with traditional face-to-face clinical services, according to study findings.

Published
31 December 2017
From
Healio
New evidence supports HIV screening in young adulthood

Study indicates that age 25 would be better than younger ages for a single HIV screening test among those without symptoms.

Published
20 December 2017
From
Science Daily
Baseline CD4 count biggest factor in long-term immune system improvements after starting HIV therapy

Pre-treatment CD4 cell count is the most important factor in immune recovery following the initiation of combination antiretroviral therapy (cART), according to the results of a large observational

Published
14 December 2017
By
Michael Carter
← First12345...162Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.